Search
Search Results
##search.searchResults.foundPlural##
-
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1548PDF: 778HTML: 141 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1359PDF: 720Suppl. Files: 303Html: 122 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1875PDF: 1067HTML: 577 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1383PDF: 736HTML: 192 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4710PDF: 1751HTML: 2103 -
CD56+/CD38+ Neutrophils: Rapid and Specific Flow Cytometric Signature for Chronic Myeloid Leukemia
34PDF: 60Suppl. Files: 14HTML: 4 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1160PDF: 733HTML: 1331Figure 1: 174Figure 2: 173 -
Osteolytic bone lesions – A rare presentation of AML M6.
1938PDF: 1065HTML: 7904Untitled: 192 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2845PDF: 1072HTML: 3020 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2529PDF: 713HTML: 2283 -
DNA Repair Genes and Chronic Myeloid Leukemia: XPD (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (1394) Gene Polymorphisms Polymorphisms of DNA Repair Genes in CML
1049PDF: 389HTML: 220 -
How I treat acute and persistent sickle cell pain
1861PDF: 1093HTML: 468 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
988PDF: 985HTML: 88 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1178PDF: 738HTML: 298 -
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3229PDF: 2238HTML: 23300Untitled: 188Untitled: 199Untitled: 216 -
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1307PDF: 490HTML: 182 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
1956PDF: 739HTML: 3102 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1348PDF: 801HTML: 3104 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12270PDF: 1649HTML: 4146Cover letter: 185Figure 1: 188 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1545PDF: 552HTML: 213 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3483PDF: 1450HTML: 4303CoverLetter: 172Figure1: 178 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1885PDF: 712HTML: 681







